(Analysis) The United States faces significant vulnerabilities in its pharmaceutical supply chain, with 90% of generic drugs reliant on active pharmaceutical ingredients (APIs) predominantly sourced from China. This dependency, exacerbated by escalating trade tariffs between the U.S. and China, raises concerns about potential disruptions to global medicine supplies. Drawing on Rosemary Gibson’s research and recent […]
The grim reality behind the grandstanding: Whats in the EUs new cash delivery to Kiev
...
Read moreDetails
